Clinical Trial Update: Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 study investigated whether ACE inhibition influences skeletal muscle weakness in chronic obstructive pulmonary disease. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ACE inhibitors

Snippet

Sponsor: Imperial College London | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED